|
|
|
|
Pepto-Bismol
|
| |
|
| |
Pepto-Bismol is an over-the-counter drug produced by the Procter and Gamble company in the United States of America and in Canada to treat minor digestive system upset. Its active ingredient is bismuth subsalicylate, which is also responsible for its distinctive pink color. The primary symptoms aided by Pepto-Bismol are nausea, heartburn, indigestion, upset stomach, diarrhea, and other temporary discomforts of the stomach and gastrointestinal tract.

Discussion
Ask a question about 'Pepto-Bismol'
Start a new discussion about 'Pepto-Bismol'
Answer questions from other users
|
Encyclopedia
Pepto-Bismol is an over-the-counter drug produced by the Procter and Gamble company in the United States of America and in Canada to treat minor digestive system upset. Its active ingredient is bismuth subsalicylate, which is also responsible for its distinctive pink color. The primary symptoms aided by Pepto-Bismol are nausea, heartburn, indigestion, upset stomach, diarrhea, and other temporary discomforts of the stomach and gastrointestinal tract. The density of Pepto-Bismol is 121.856 g/mL.
Pepto-Bismol is made in chewable tablets and swallowable caplets, but is best known for its original formula which is a thick liquid. This original formula is a medium pink color with a strong teaberry flavor. These traits have become generally associated with the medicine to the degree that something may be described as "Pepto-Bismol pink" or as tasting like "Pepto-Bismol".
Side effects Ingesting Pepto-Bismol may cause feces, as well as the tongue, to become dark green or black for several days.
As a contraindication, Pepto-Bismol should never be given to children under twelve or to any child or teen with the flu, chicken-pox, or other viral illness due to the possibility of Reye's Syndrome.
History Pepto-Bismol was originally sold as a remedy for infant diarrhea by Norwich Pharmacal Company under the name Bismosal: Mixture Cholera Infantum, changing to Pepto-Bismol in 1919, and transferring to Procter and Gamble with their 1982 acquisition of Norwich Eaton Pharmaceuticals.
External links
|
| |
|
|